Lemaitre Vascular (LMAT) | Stock Overview & Key Data
Lemaitre Vascular Performance Comparison
Stock Range
Today's Range
Low: $87.00
High: $88.15
on October 6, 2025
52 Week Range
Low: $71.42
High: $109.58
on April 7, 2025
on November 25, 2024
All-Time High: $109.58 on November 25, 2024
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$2.0B
EPS
2.05
P/E Ratio (TTM)
42.85
Forward P/E
40.48
P/B Ratio
5.48
PEG Ratio
2.84
Div. Yield
0.98%
ROE
13.81%
Beta
0.766
Debt to Equity
51.25
Financial Highlights
Profitability
Gross Margin
70.02%
Operating Margin
25.13%
Profit Margin
20.08%
Returns and Earnings
Return on Assets (TTM)
7.28%
Return on Equity (TTM)
13.81%
EBITDA
$75.7M
Net Income (TTM)
$47.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$10.41
Quarterly Revenue Growth (YoY)
15.00%
Quarterly Earnings Growth (YoY)
16.50%
Dividend Information
Last 12-Month Dividend
$0.92
Current Dividend Yield
0.98%
3-Year Average Dividend Yield
0.23%
3-Year Average Annual Dividend
$0.68
3-Year Total Dividends
$2.04
Ex-Dividend Date
August 21, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Lemaitre Vascular LMAT | 1.99B Small-cap | 4.35% | -7.10% | 4.10% | 7.34% | -3.96% | -4.11% | 80.87% | 162.71% |
| Intuitive Surgical ISRG | 163.30B Large-cap | 2.55% | 2.53% | -16.92% | -8.54% | -13.68% | -6.14% | 139.74% | 83.84% |
| Becton, Dickinson BDX | 55.67B Large-cap | 4.88% | 2.11% | 9.91% | -12.63% | -14.52% | -18.73% | -13.05% | -16.37% |
| AtriCure ATRC | 1.78B Small-cap | -1.11% | 0.12% | 9.60% | 5.74% | 14.51% | 25.99% | -9.23% | -15.82% |
| Azenta AZTA | 1.51B Small-cap | 13.62% | 10.49% | -2.35% | 3.67% | -35.15% | -32.77% | -22.57% | -38.25% |
| Anbio Biotechnology NNNN | 1.41B Small-cap | -7.96% | -31.98% | -13.06% | 342.37% | 457.37% | 457.37% | 457.37% | 457.37% |
Ownership & Short Interest
Insider Ownership
7.80%
Institutional Ownership
95.35%
Shares Short
1M
Short Ratio
7.04
Short % of Shares Outstanding
7.58%
Average 10-Day Volume
165K
Average 90-Day Volume
183K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is LMAT's 52-week high and low?
- In the last 52 weeks, Lemaitre Vascular reached a high of $109.58 (on November 25, 2024) and a low of $71.42 (on April 7, 2025).
- What is the market cap and P/E ratio for LMAT?
- Curious about Lemaitre Vascular's size and valuation? Its market capitalization stands at 1.99B. When it comes to valuation, the P/E ratio (trailing twelve months) is 42.85, and the forward P/E (looking ahead) is 40.48.
- Does LMAT pay dividends? If so, what's the yield?
- Yes, Lemaitre Vascular is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.98%, and the company has paid an average of $0.68 per share annually over the past 3 years.
- Who are Lemaitre Vascular's main competitors or similar companies to consider before investing?
When looking at Lemaitre Vascular, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Intuitive Surgical
ISRG163.30B Healthcare Medical Instruments & Supplies -6.14% 139.74% Becton, Dickinson
BDX55.67B Healthcare Medical Instruments & Supplies -18.73% -13.05% AtriCure
ATRC1.78B Healthcare Medical Instruments & Supplies 25.99% -9.23% Azenta
AZTA1.51B Healthcare Medical Instruments & Supplies -32.77% -22.57% Anbio Biotechnology
NNNN1.41B Healthcare Medical Instruments & Supplies 457.37% 457.37% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Lemaitre Vascular Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Lemaitre Vascular's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 13.81%, the Debt to Equity ratio from the most recent quarter is 51.25, and its Gross Profit Margin stands at 70.02%.
- What is the recent revenue and earnings growth for LMAT?
- Looking at Lemaitre Vascular's growth, its revenue over the trailing twelve months (TTM) was $235M. Compared to the same quarter last year (YoY), quarterly revenue grew by 15.00%, and quarterly earnings saw a YoY growth of 16.50%.
- How much of LMAT stock is held by insiders and institutions?
- Wondering who owns Lemaitre Vascular stock? Company insiders (like executives and directors) hold about 7.80% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 95.35%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.